Important notice

Labour dispute at Canada Post

We have put in place measures to mitigate the impact on our clients.

Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4762 results found.

Example of search result explained

Abrilada (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Pfizer Canada Inc. (Pfizer)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114034

Amgevita (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Amgen Canada Inc. (Amgen)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114047

Idacio (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Fresenius Kabi Canada Ltd. (Fresenius)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114265

Idacio (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Fresenius Kabi Canada Ltd. (Fresenius)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114267

Hyrimoz (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (uveitis)
  • Manufactured by:
    Sandoz Canada Inc (Sandoz)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,2 mL) DIN : 99114304
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114305
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 99114307
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 99114107
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114108

Hadlima PushTouch (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (uveitis)
  • Manufactured by:
    Organon Canada Inc. (Organon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114232
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114230

Hadlima (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (uveitis)
  • Manufactured by:
    Organon Canada Inc. (Organon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114231
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114229

Hyrimoz (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (uveitis)
  • Manufactured by:
    Sandoz Canada Inc (Sandoz)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114306
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 99114308
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114109

Simlandi (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (uveitis)
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114145
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 99114147

Simlandi (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (uveitis)
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114150
Page 13 of 477

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.